Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.clon.2021.08.003

PubMed Identifier: 34479769

Publication URI: http://europepmc.org/abstract/MED/34479769

Type: Journal Article/Review

Volume: 34

Parent Publication: Clinical oncology (Royal College of Radiologists (Great Britain))

Issue: 1

ISSN: 0936-6555